Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Treatment 1 (Initial Drug Assignment)	STARTED	Standard Dose First, Then High Dose	16
Treatment 1 (Initial Drug Assignment)	STARTED	High Dose First, Then Standard Dose	15
Treatment 1 (Initial Drug Assignment)	COMPLETED	Standard Dose First, Then High Dose	16
Treatment 1 (Initial Drug Assignment)	COMPLETED	High Dose First, Then Standard Dose	11
Treatment 1 (Initial Drug Assignment)	NOT COMPLETED	Standard Dose First, Then High Dose	0
Treatment 1 (Initial Drug Assignment)	NOT COMPLETED	High Dose First, Then Standard Dose	4
Treatment 2	STARTED	Standard Dose First, Then High Dose	16
Treatment 2	STARTED	High Dose First, Then Standard Dose	11
Treatment 2	COMPLETED	Standard Dose First, Then High Dose	16
Treatment 2	COMPLETED	High Dose First, Then Standard Dose	11
Treatment 2	NOT COMPLETED	Standard Dose First, Then High Dose	0
Treatment 2	NOT COMPLETED	High Dose First, Then Standard Dose	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00362297/flow